Drug metabolic enzymes in developmental toxicology

Fundamental and Applied Toxicology

Volumn 34, Issue 2, 1996, Pages 165-175

  Miller, Mark Steven ^a   Juchau, Mont R ^b   Guengerich, F Peter ^c   Nebert, Daniel W ^d   Raucy, Judy L ^e  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e AGOURON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ISOENZYME;

CELL LINE; CONFERENCE PAPER; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME ASSAY; GENE CONSTRUCT; GENE EXPRESSION; HUMAN; IN VITRO STUDY; LANGUAGE DEVELOPMENT; LIVER; LIVER METABOLISM; LUNG TUMOR; MUTATION; NONHUMAN; ONCOGENE; ORGANOGENESIS; PRENATAL EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; XENOBIOTIC METABOLISM;

EID: 26844447583     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0187     Document Type: Conference Paper

References (70)

1. Albano, E., Toamsi, A., Persson, J. O., Terelius, Y., Goria-Gatti, L., Ingelman-Sundberg, M., and Dianzani, M. U. (1991). Role of ethanol-inducible cytochrome P450 (P450IIE1) in catalysing the free radical activation of aliphatic alcohols. Biochem. Pharmacol. 41, 1895-1902.
2. Al-Shawi, R., Burke, J., Wallace, H., Jones, C., Harrison, S., Buxton, D., Maley, S., Chandley, A., and Bishop, J. O. (1991). The herpes simplex virus type-1 thymidine kinase is expressed in the testes of transgenic mice under the control of a cryptic promoter. Mol. Cell. Biol. 11, 4207-4216.
3. Anderson, L. M., Jones, A. B., Riggs, C. W., and Ohshima, M. (1985). Fetal mouse susceptibility to transplacental lung and liver carcinogenesis by 3-methylcholanthrene: Positive correlation with responsiveness to inducers of aromatic hydrocarbon metabolism. Carcinogenesis, 6, 1389-1393.
4. Anderson, L. M., Jones, A. B., Miller, M. S., and Chauhan, D. P. (1989). Metabolism of transplacental carcinogens. In Transplacental and Multigeneration Carcinogenesis (N. P. Napalkov, J. M. Rice, L. Tomatis, and H. Yamasaki, Eds.), pp. 155-188. IARC Scientific Publications No. 96.
5. Bedell, M. A., Jenkins, N. A., and Copeland, N. G. (1996). Good genes in bad neighbourhoods. Nature Genet. 12, 229-232.
6. Bradley, A., Evans, M., Kaufman, M. H., and Robertson, E. (1984). Formation of germ-line chimeras from embryo-derived teratocarcinoma cell lines. Nature 309, 255-256.
7. Bronson, S. K., and Smithies, O. (1994). Altering mice by homologous recombination using embryonic stem cells. J. Biol. Chem. 269, 27155-27158.
8. Bunin, G. R., Kramer, S., Marrero, O., and Meadows, A. T. (1987). Gestational risk factors for Wilms' tumor: Results of a case-control study. Cancer Res. 47, 2972-2977.
9. Capecchi, M. R. (1987). The new mouse genetics: Altering the genome by gene targeting. Trends Genet. 5, 70-76.
10. Carpenter, S. P., Lasker, J. M., and Raucy, J. L. (1996). Expression, induction and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver. Mol. Pharmacol. 49, 260-268.
11. Deuschle, U., Meyer, W. K. H., and Thiesen, H. J. (1995). Tetracycline-reversible silencing of eukaryotic promoters. Mol. Cell. Biol. 15, 1907-1914.
12. Diebold, R. J., Eis, M. J., Yin, M., Ormsby, I., Boivin, G. P., Darrow, B. J., Saffitz, J. E., and Doetschman, T. (1995). Early-onset multifocal inflammation in the transforming growth factor β1-null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci. USA 92, 12215-12219.
13. Efrat, S., Fusco-DeMane, D., Lemberg, H., Al Emran, O., and Wang, X. (1995). Conditional transformation of a pancreatic β-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc. Natl. Acad. Sci. USA 92, 3576-3580.
14. Ekstrom, G., and Ingelman-Sundberg, M. (1989). Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P450. Biochem. Pharmacol. 38, 1813-1819.
15. Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S. T., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., and Gonzalez, F. J. (1995). Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268, 722-726.
16. Gossen, M., and Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547-5551.
17. Gossen, M., Bonin, A. L., and Bujard, H. (1993). Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biol. Sci. 18, 471-475.
18. Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., and Bujard, H. (1995). Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
19. Gu, H., Zou, Y. R., and Rajewsky, K. (1993). Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73, 1155-1164.
20. Gu, H., Marth, J. D., Orban, P. C., Mossmann, H., and Rajewsky, K. (1994). Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 265, 103-106.
21. Hansen, C., Sørensen, L. D., Asmussen, I., and Autrup, H. (1992). Transplacental exposure to tobacco smoke in human-adduct formation in placenta and umbilical cord blood vessels. Teratogen. Carcinogen. Mutagen. 12, 51-60.
22. Hillen, W., and Berens, C. (1994). Mechanisms underlying expression of Tn10-encoded tetracycline resistance. Annu. Rev. Microbiol. 48, 345-404.
23. Hulla, J. E., and Juchau, M. R. (1989). Occurrence and inducibility of cytochrome P450IIIA in maternal and fetal rats during prenatal development. Biochemistry 28, 4871-4880.
24. John, E. M., Savitz, D. A., and Sandler, D. P. (1991). Prenatal exposure to parents' smoking and childhood cancer. Am. J. Epid. 133, 123-132.
25. Jones, K. L., and Smith, D. W. (1973). Recognition of the fetal alcohol syndrome in early infancy. Lancet II, 999-1001.
26. Juchau, M. R. (1989). Bioactivation in chemical teratogenesis. Annu. Rev. Pharmacol. Toxicol. 29, 165-187.
27. Juchau, M. R., Lee, Q. P., and Fantel, A. G. (1992). Xenobiotic biotransformation/bioactivation in organogenesis-stage conceptal tissues: Implications for embryotoxicity and teratogenesis. Drug Metab. Rev. 24, 195-238.
28. Kitamura, M. (1996). Creation of a reversible on/off system for site-specific in vivo control of exogenous gene activity in the renal glomerulus. Proc. Natl. Acad. Sci. USA 93, 7387-7391.
29. Koop, D. R. (1992). Oxidative and reductive metabolism by cytochrome P4502E1. FASEB J. 6, 724-730.
30. Kühn, R., Schwenk, F., Aguet, M., and Rajewsky, K. (1995). Inducible gene targeting in mice. Science 269, 1427-1429.
31. Lee, Q. P., Fantel, A. G., and Juchau, M. R. (1991). Human embryonic cytochrome P450s: Phenoxazone ethers as probes for expression of functional isoforms during organogenesis. Biochem. Pharmacol. 42, 2377-2386.
32. Li, Z. W., Stark, G., Götz, J., Rülicke, T., and Müller, U. (1996). Generation of mice with a 200-kb amyloid precursor protein gene deletion by Cre recombinase-mediated site-specific recombination in embryonic stem cells. Proc. Natl. Acad. Sci. USA 93, 6158-6162.
33. Liang, H. C., Li, H., McKinnon, R. A., Duffy, J. J., Potter, S. S., Puga, A., and Nebert, D. W. (1995). Cyp1a2(-/-) null mutant mice develop normally, but show deficient drug metabolism. Proc. Natl. Acad. Sci. USA 93, 1671-1676.
34. Manchester, D. K., Bowman, E. D., Parker, N. B., Caporaso, N. E., and Weston, A. (1992). Determinants of polycyclic aromatic hydrocarbonDNA adducts in human placenta. Cancer Res. 52, 1499-1503.
35. Miller, M. S., Jones, A. B., Chauhan, D. P., Park, S. S., and Anderson, L. M. (1989). Differential induction of fetal mouse liver and lung cytochromes P-450 by β-naphthoflavone and 3-methylcholanthrene. Carcinogenesis 10, 875-883.
36. Miller, M. S., Jones, A. B., and Anderson, L. M. (1990a). The formation of 3-methylcholanthrene-initiated lung tumors correlates with induction of cytochrome CYPIA1 by the carcinogen in fetal but not adult mice. Toxicol. Appl. Pharmacol. 104, 235-245.
37. Miller, M. S., Jones, A. B., Chauhan, D. P., and Anderson, L. M. (1990b). Role of the maternal environment in determining susceptibility to transplacentally induced chemical carcinogenesis in mouse fetuses. Carcinogenesis 11, 1979-1984.
38. Miller, M. S. (1994). Transplacental lung carcinogenesis: A pharmacogenetic mouse model for the modulatory role of cytochrome P450 1A1 on lung cancer initiation. Res. Chem. Toxicol. 7, 471-481.
39. Milot, E., Fraser, P., and Grosveld, F. (1996). Position effects and genetic disease. Trends Genet. 12, 123-126.
40. Mitsudomi, T., Viallet, J., Mulshine, J. L., Linnoila, R. I., Minna, J. D., and Gazdar, A. F. (1991). Mutations of ras genes distinguish a subset of non-small cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene, 6, 1353-1362.
41. Mortensen, R. M., Conner, D. A., Chao, S., Geisterfer-Lowrance, A. A., and Seidman, J. G. (1992). Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell. Biol. 12, 2391-2395.
42. Namkung, M. J., Yang, H. L., and Juchau, M. R. (1994). Cytochrome P450-dependent biotransformation of 2-acetylaminofluorene in cell-free preparations of human embryonic hepatic, adrenal, renal, pulmonary and cardiac tissues. Drug Metab. Dispos. 22, 331-337.
43. Nebert, D. W. (1989). The Ah locus: Genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 20, 153-174.
44. Nebert, D. W. (1994). Drug-metabolizing enzymes in ligand-modulated transcription. Biochem. Pharmacol. 47, 25-37.
45. Nebert, D. W., Puga, A., and Vasiliou, V. (1993). Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer and in signal transduction. Ann. N. Y. Acad. Sci. 685, 624-640.
46. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C., and Nebert, D. W. (1996). P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42.
47. Olson, E. N., Arnold, H. H., Rigby, P. W. J., and Wold, B. J. (1996). Know your neighbors: Three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85, 1-4.
48. Orban, P. C., Chui, D., and Marth, J. D. (1992). Tissue-and site-specific DNA recombination in transgenic mice. Proc. Natl. Acad. Sci. USA 89, 6861-6865.
49. Osborne, M. R., Brookes, P., Lee, H., and Harvey, R. G. (1986). The reaction of a 3-methylcholanthrene diol epoxide with DNA in relation to the binding of 3-methylcholanthrene to the DNA of mammalian cells. Carcinogenesis 7, 1345-1350.
50. Pelkonen, O. (1985). Fetoplacental biochemistry - xenobiotic metabolism and pharmacokinetics. In Occupational Hazards and Reproduction (K. Hemminki, M. Sorsa, and H. Vainio, Eds.) pp. 113-126. Hemisphere, Washington, DC.
51. Peter, R., Bocker, R., Beaune, P. H., Iwasaki, M., Guengerich, F. P., and Yang, C. S. (1990). Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIE1. Chem. Res. Toxicol. 3, 566-573.
52. Pikkarainen, P. H. (1971). Metabolism of ethanol and acetaldehyde in perfused human fetal liver. Life Sci. 10, 1359-1364.
53. Pineau, T., Fernandez-Salguero, P., Lee, S. T. T., McPhail, T., Ward, J. M., and Gonzalez, F. J. (1995). Neonatal lethality associated with respiratory distress in mice lacking cytochrome P450 1A2. Proc. Natl. Acad. Sci. USA 92, 5134-5138.
54. Raucy, J. L., Lasker, J. M., Lieber, C. S., and Black, M. (1989). Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch. Biochem. Biophys. 271, 270-283.
55. Raucy, J. L., and Carpenter, S. J. (1993). The expression of xenobiotic-metabolizing cytochromes P450 in fetal tissues. J. Pharmacol. Toxicol. Methods 29, 121-128.
56. Schmidt, J. V., Su, G. H. T., Reddy, J. K., Simon, M. C., and Bradfield, C. A. (1996). Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. USA 93, 6731-6736.
57. Schwenk, F., Baron, U., and Rajewsky, K. (1995). A Cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080-5081.
58. Sibilia, M., and Wagner, E. F. (1995). Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269, 234-238.
59. Spencer, D. M. (1996). Creating conditional mutations in mammals. Trends Genet. 12, 181-187.
60. Stjernfeldt, M., Berglund K., Lindsten, J., and Ludvigsson, J. (1986). Maternal smoking during pregnancy and risk of childhood cancer. Lancet 1, 1350-1352.
61. Thomas, K. R., and Capecchi, M. R. (1987). Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512.
62. Threadgill, D. W., Dlugosz, A. A., Hansen, L. A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R. C., Barnard, J. A., Yuspa, S. H., Coffey, R. J., and Magnuson, T. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype. Science 269, 230-234.
63. Van Deursen, J., Fornerod, M., van Rees, B., and Grosveld, G. (1995). Cre-mediated site-specific translocation between nonhomologous mouse chromosomes. Proc. Natl. Acad. Sci. USA 92, 7376-7380.
64. Vasiliou, V., Puga, A., Chang, C. Y., Tabor, M. W., and Nebert, D. W. (1995). Interaction between the Ah receptor and proteins binding to the AP-1-like electrophile response element (EpRE) during murine Phase II [Ah] battery gene expression. Biochem. Pharmacol. 50, 2057-2068.
65. Wessner, L. L., Fan, M., Schaeffer, D. O., McEntee, M. F., and Miller, M. S. (1996). Induction of activating gene mutations at the Ki-ras locus following transplacental exposure of mice to 3-methylcholanthrene. Carcinogenesis 7, 1519-1526.
66. West, J. R. (1987). Fetal alcohol-induced brain damage and the problem of determining temporal vulnerability: A review. Alcohol Drug Res. 7, 423-441.
67. Whyatt, R. M., Garte, S. J., Cosma, G., Bell, D. A., Jedrychowski, W., Wahrendorf, J., Randall, M. C., Cooper, T. B., Ottman, R., Tang, D., Tsai, W.-Y., Dickey, C. P., Manchester, D. K., Crofts, F., and Perera, F. P. (1995). CYP1A1 messenger RNA levels in placental tissue as a biomarker of environmental exposure. Cancer Epidemiol. Biomarkers Prev. 4, 147-153.
68. Yang, C. S., Yoo, J. S. H., Ishizaki, H., and Hong, J. (1990). Cytochrome P450IIE1 roles of nitrosamine metabolism and mechanisms of regulation. Drug Metab. Rev. 22, 147-153.
69. Yang, H. L., Lee, Q. P., Rettie, A. E., and Juchau, M. R. (1994). Functional P4503A isoforms in human embryonic tissues: Expression during organogenesis. Mol. Pharmacol. 46, 922-929.
70. Yang, H. L., Namkung, M. J., and Juchau, M. R. (1995). Expression of functional cytochrome P4501A1 in human embryonic hepatic tissues during organogenesis. Biochem. Pharmacol. 49, 717-726.